<DOC>
	<DOCNO>NCT02451202</DOCNO>
	<brief_summary>It unknown impact deep neuromuscular paralysis use novel agent , sugammadex reversal endolaryngeal surgery . We conduct clinical study aim compare two treatment strategy ; Deep neuromuscular Blockade moderate Neuromuscular Blockade . We hypothesize deep NMB offer good stillness . We also descriptively examine patient would safely discharge recovery room .</brief_summary>
	<brief_title>Deep v Moderate Neuromuscular Blockade With Rocuronium Patients Undergoing Endolaryngeal Procedures</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Male female age 18 60 year ; ASA IIII . Subjects plan elective endolaryngeal . Procedures ( Direct Laryngoscopy laser ( micro ) surgery patient Tis , T1 , T2 , supraglottis glottis carcinoma ) Any renal impairment ( CrCL &lt; 80 ml/ min ) Any hepatic impairment ; Child Pugh A , B C BMI &gt; 30 kg m2 Known suspect generalized neuromuscular disorder Allergies Rocuronium , Sugammadex , Sevoflurane , Propofol , fentanyl use general anesthesia Hypersensitivity active substance excipients Female patient pregnant breastfeeding . Patient poor Glasgow Coma Score mental derangement unable give inform consent . Patient Tracheostomy tube .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>`` surgical condition ''</keyword>
	<keyword>`` deep neuromuscular blockade ''</keyword>
	<keyword>`` deep neuromuscular paralysis ''</keyword>
</DOC>